Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib

Total article views   HTML views PDF downloads Totals
21,008 Dovepress* 17,762+ 1,891 19,653
PubMed Central* 3,246 365 3,611
Totals 21,008 2,256 23,264
*Since 5 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
16 0 0 1 7 8

View citations on PubMed Central and Google Scholar